Last edition
News about
India's Pharma Exports Set to Cross USD 30 Billion by Year-End: Dr Jitendra Singh
India’s pharma exports, currently valued at nearly USD 27.8 billion, are expected to cross USD 30 billion by the end of this year, Union Minister Dr. Jitendra Singh said.
Biocon Biologics, Amgen Settle Patent Dispute, Paving Way for US Launch of Denosumab Biosimilars
The agreement with Amgen enables Biocon Biologics to launch denosumab biosimilars Bosaya and Aukelso in the US from October 1, 2025.
Lupin Receives Approval from US FDA for Rivaroxaban for Oral Suspension
Lupin’s Rivaroxaban will be manufactured at the company’s Chhatrapati Sambhajinagar facility.
CCT Launches New Campaign to Elevate Digitalisation in Pharma Logistics
Leading temperature-controlled solution provider Cold Chain Technologies (CCT) has launched a new campaign titled “Smart Chain, Clear Gain,” aimed at redefining how pharmaceutical companies approach compliance, efficiency and value in cold chain logistics.
CDSCO Clarifies Approval Process for Lyophilized Injection Combi-Packs
The drug regulator has specified when combi-packs of lyophilized injections with diluents will require fresh CDSCO approval and when licenses can be issued directly by State Licensing Authorities.
Novo Nordisk to Launch Ozempic in India
The once-a-week injectable, Ozempic will complement Novo Nordisk’s existing oral Semaglutide for diabetes and recently approved WeGovy for obesity.
FUJIFILM Opens Commercial-Scale Cell Culture Manufacturing Site in North Carolina
FUJIFILM Biotechnologies recently inaugurated its new manufacturing facility in Holly Springs, North Carolina, marking the addition to its global network. The company stated that the site ranks among the largest commercial-scale cell culture biomanufacturing facilities in North America.
Nyxoah Expands Its Presence in Middle East
Nyxoah expands in the Middle East (ME) with new centres in Dubai, Kuwait and Abu Dhabi after the first Genio implant.
Kai Beckmann to Lead Merck as CEO and Executive Board Chair
The Board of Partners of E. Merck KG appointed Kai Beckmann as future Chairman of the Executive Board and CEO of Merck. Belén Garijo’s tenure to be completed as planned by end of April 2026.
Mstack launches R&D platform Chemstack AI
Mstack's rapid expansion reflects extraordinary market demand for supply chain diversification, scaling to over 100 enterprise customers across North America, India, China and the Middle East, with over 100 employees spanning data science, AI, technology development, R&D, operations, and sales.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy